Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
FDA Approves Finerenone for Heart Failure with LVEF ≥40%
Added: 3 months ago Source:  Radcliffe Cardiology
The US Food and Drug Administration (FDA) has approved the non-steroidal, selective mineralocorticoid receptor antagonist (nsMRA) finerenone (Kerendia, Bayer). The new indication is for adult patients with heart failure (HF) and a left ventricular ejection fraction (LVEF) of ≥40% to reduce the risk of cardiovascular death, hospitalisation for heart failure, and urgent heart failure visits.¹ The… View more

Cardiovascular Renal Metabolic

Guidelines & Statements
Guideline-directed Medical Therapy is the Most Effective Decongestion
Author(s): Jelena Celutkiene , Alexandre Mebazaa , Jan Biegus , et al Added: 10 months ago

Heart Failure
Understanding the Role of GLP-1 RAs in the Treatment of HF
Author(s): Giovanni Battista Bonfioli , Matteo Pagnesi , Daniela Tomasoni , et al Added: 4 months ago

Cardiovascular Renal Metabolic
Malnutrition and Prognosis in Elderly Patients with Chronic Heart Failure
Author(s): Mohammed El-Sheikh , Nora Olsen El Caidi , Aginsha Kandiah , et al Added: 1 month ago

Cardiovascular Renal Metabolic

Heart Failure
The True Obesity Paradox: Obese and Malnourished?
Author(s): Mohammed El-Sheikh , Nora Olsen El Caidi , Aginsha Kandiah , et al Added: 9 months ago

Cardiovascular Renal Metabolic
Background of Heart Failure
Author(s): Raluca Ibănescu , Diana-Alexandra Mîțu , Iacob-Daniel Goje , et al Added: 8 months ago

Imaging & Diagnostics

Heart Failure
Pharmacological Therapy of HFrEF in 2025
Author(s): Massimo Mapelli , Filippo Maria Rubbo , Simona Costantino , et al Added: 4 months ago

Heart Failure
Aldosterone and Potassium in Heart Failure
Author(s): Laibah Arshad Khan , Adeena Jamil , Stephen J Greene , et al Added: 11 months ago

Heart Failure

Prevention & Chronic Conditions